Doctor of Podiatric Medicine Program year 2022 Reported 2019–2022 Source: CMS Open Payments, 2026 publication

Jeffery Griert

Podiatrist, Primary Podiatric Medicine Pearland, TX Doctor of Podiatric Medicine

NPI 1609982867 CMS profile 300184

10970 Shadow Creek Pkwy Ste 260, Jmg Podiatry, Pearland, TX 77584

Open in the dashboard

General payments

$559

14 records reported · program years 2019–2022

Research payments

$0

Paid to them · None reported · program years 2019–2022

Ownership & investment interest

$0

None reported

Through program year 2022, Jeffery Griert of Pearland, TX is reported in the CMS Open Payments database as having received $559 across 14 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 48th percentile of Podiatrist, Primary Podiatric Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2022 General $216 2
2021 General $108 3
2019 General $235 9

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jeffery Griert
  • Podiatrist, Primary Podiatric Medicine median
  • Middle half of Podiatrist, Primary Podiatric Medicine
  • National median

In program year 2025, general payments to Jeffery Griert were reported at $0. Among 368 Podiatrist, Primary Podiatric Medicine profiles paid that year, the median was $232 and the middle half received between $88 and $586.

Show as a table
Year Jeffery Griert Podiatrist, Primary Podiatric Medicine median Middle half National median
2019 $235 $166 $51–$513 $163
2020 $0 $108 $33–$249 $114
2021 $108 $147 $52–$377 $132
2022 $216 $188 $66–$551 $149
2023 $0 $195 $70–$509 $160
2024 $0 $209 $59–$508 $164
2025 $0 $232 $88–$586 $169

Breakdown

Who paid General payments · program years 2019–2022
  1. Smith+Nephew, Inc. $150 4 payments
  2. Organogenesis Inc. $114 1 payment
  3. Heron Therapeutics, Inc. $102 1 payment
  4. AbbVie, Inc. $96 2 payments
  5. Dexcom, Inc. $40 2 payments
  6. Musculoskeletal Transplant Foundation Inc. $32 2 payments
  7. Horizon Therapeutics plc $14 1 payment
  8. Orthofix Medical, Inc. $11 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2022
  1. Food and Beverage $557 13 payments
  2. Travel and Lodging $2 1 payment
Products named General payments · program years 2019–2022
  1. Santyl $150 4 payments
  2. Puraply $114 1 payment
  3. Zynrelef $102 1 payment
  4. DALVANCE $96 2 payments
  5. DEXCOM CGM $40 2 payments
  6. REGRANEX $26 2 payments
  7. RAYOS Rayos $14 1 payment
  8. RAYOS Rayos $14 1 payment
  9. RAYOS Rayos $14 1 payment
  10. Spinal-Stim Osteogenesis Stimulator $11 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 29 billing codes

Paid by Medicare

$254,452

Medicare's payments for the services billed

Medicare patients

436

Average age 82

Services billed

4,766

260 women, 176 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 58%
Diabetes 53%
Chronic kidney disease 46%
Ischemic heart disease 45%
Alzheimer's or dementia 44%
Depression 41%
Heart failure 40%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

14 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Podiatrist, Primary Podiatric Medicine in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2022

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record